This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03269/identifier/chemspider/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n5http://linked.opendata.cz/resource/drugbank/drug/DB03269/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03269/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03269/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB03269/identifier/drugbank/

Statements

Subject Item
n2:DB03269
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB03269 n11:DB03269
dcterms:title
4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5,6-Enyl)Amino)Fructose
adms:identifier
n4:DB03269 n5:AF1 n12:1672 n13:46936324 n14:46506058
n6:IUPAC-Name
n7:271B5F7B-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B5F81-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B5F80-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B5F7D-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B5F7E-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B5F7F-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B5F79-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B5F7A-363D-11E5-9242-09173F13E4C5 n7:271B5F77-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B5F78-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B5F87-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B5F88-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B5F82-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B5F83-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B5F85-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B5F84-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B5F86-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B5F8D-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B5F8F-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B5F90-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B5F8C-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B5F8B-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B5F8E-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B5F7C-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B5F89-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B5F8A-363D-11E5-9242-09173F13E4C5